Bioceres Crop Solutions (BIOX) AI Stock Analysis

• Market Cap: $111.00M
• Dividend Yield: N/A
• Average Volume (3M): 1.08M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.58
• Revenue Growth: -27.90%
• EPS Growth: -4194.67%
• Country: US
• Employees: 400
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): -0.12
• Shares Outstanding: 62,710,846
• 10 Day Avg. Volume: 1,709,433
• 30 Day Avg. Volume: 1,077,044
• PEG Ratio: <0.01
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.85
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.00
• Enterprise Value/Revenue: 0.00
• Enterprise Value/Gross Profit: 0.00
• Enterprise Value/Ebitda: 0.00
• 1Y Price Target: $3.63
• Price Target Upside: 124.07% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: $1.50 ▼(-7.41% Downside)

Bioceres Crop Solutions is facing a challenging financial environment with declining revenues and profitability. While there are improvements in cash flow and cost efficiency, high leverage and negative returns on equity are significant concerns. The technical indicators suggest a bearish trend, and the valuation is unattractive due to a negative P/E ratio. The earnings call provided some positive insights into margin improvements, but these are overshadowed by revenue declines and debt issues.

Positive Factors

Gross Margin Expansion

The significant expansion in gross margin indicates improved product mix and operational efficiency, which can enhance long-term profitability.

Leadership Strengthening

New leadership appointments can strengthen strategic and financial governance, potentially improving market position and operational resilience.

Cash Flow Improvement

Improved cash flow generation enhances financial flexibility and supports strategic investments, crucial for long-term growth and stability.

Negative Factors

Revenue Decline

A significant decline in revenue can impact the company's ability to invest in growth and maintain competitive positioning.

Debt Dispute

Ongoing legal disputes over debt can strain financial resources and distract management, potentially affecting long-term strategic focus.

Market Challenges in Argentina

Macroeconomic challenges in key markets like Argentina can limit growth opportunities and affect revenue stability over the medium term.

Bioceres Crop Solutions Business Overview & Revenue Model

Company Description

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.

How the Company Makes Money

Bioceres Crop Solutions generates revenue through several key streams. First, it sells proprietary seed traits that are designed to improve crop performance and resistance to various stresses. Second, the company offers crop protection products, which include biological and chemical solutions aimed at safeguarding crops from pests and diseases. Additionally, Bioceres has developed partnerships with agricultural distributors and other industry players, which help expand its market reach and enhance its product offerings. The company also benefits from licensing agreements and collaborations in research and development, allowing it to capitalize on its innovations while sharing the financial risks associated with new product development. Overall, Bioceres' revenue model is built on a combination of direct sales, partnerships, and strategic collaborations that leverage its expertise in agricultural biotechnology.

Bioceres Crop Solutions Financial Statement Overview

Summary

Bioceres Crop Solutions shows solid cash flow management and a strong equity base, but profitability and revenue stability are concerns. High debt levels and inconsistent profitability metrics suggest potential financial risk. Focus should be on stabilizing net income and managing leverage.

Income Statement

Bioceres Crop Solutions shows volatile revenue trends with significant fluctuations in net income, indicating instability. The company has recently experienced a negative net profit margin and declining EBIT margins in TTM. Despite past growth, the current revenue trajectory suggests a need for consistency in profitability.

Balance Sheet

The company's balance sheet shows moderate leverage with a debt-to-equity ratio that has increased over time, indicating rising financial risk. However, the equity ratio remains healthy, reflecting a strong equity position. The ROE has been inconsistent, highlighting the need for improved profitability.

Cash Flow

The cash flow analysis indicates robust operating cash flow relative to net income in TTM, suggesting effective cash management. However, fluctuations in free cash flow growth and historical negative free cash flows point to potential liquidity concerns. The company needs to stabilize free cash flow generation.

Breakdown	TTM	Dec 2025	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	333.40M	―	333.30M	464.83M	419.45M	328.46M
Gross Profit	130.00M	―	130.20M	181.59M	180.25M	126.44M
EBITDA	15.19M	―	13.59M	55.45M	72.38M	47.91M
Net Income	-51.00M	―	-51.80M	3.24M	18.78M	-7.20M
Balance Sheet
Total Assets	763.65M	―	763.65M	852.55M	818.06M	518.22M
Cash, Cash Equivalents and Short-Term Investments	34.74M	―	34.74M	56.17M	60.05M	38.61M
Total Debt	276.61M	―	276.61M	270.95M	257.41M	169.79M
Total Liabilities	468.43M	―	468.43M	501.17M	487.56M	359.92M
Stockholders Equity	262.81M	―	262.81M	315.30M	298.85M	127.61M
Cash Flow
Free Cash Flow	28.71M	―	35.30M	18.93M	-19.97M	-26.51M
Operating Cash Flow	39.87M	―	49.91M	41.72M	2.59M	-17.52M
Investing Cash Flow	-6.13M	―	-6.13M	-28.73M	-25.73M	2.90M
Financing Cash Flow	-50.71M	―	-50.71M	-10.06M	32.95M	14.82M

Bioceres Crop Solutions Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.62
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BIOX, the sentiment is Negative. The current price of 1.62 is below the 20-day moving average (MA) of 1.67, below the 50-day MA of 1.65, and below the 200-day MA of 3.44, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 47.39 is Neutral, neither overbought nor oversold. The STOCH value of 75.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BIOX.

Bioceres Crop Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
RKDA	50 Neutral	$4.83M	-0.64	-64.08%	―	-1.80%	15.74%
BIOX	49 Neutral	$111.00M	-2.16	-20.52%	―	-27.90%	-4194.67%
AVD	47 Neutral	$130.10M	―	-40.84%	―	-4.29%	-276.74%
SEED	46 Neutral	$11.02M	-23.04	―	―	-21.82%	-104.92%
LVRO	44 Neutral	$110.38M	―	―	―	―	―
BHST	41 Neutral	$152.46M	―	-200.22%	―	45.88%	43.12%

Bioceres Crop Solutions Corporate Events

Bioceres Crop Solutions Releases Q3 2025 Financial Update

Bioceres Crop Solutions Corp. released its unaudited interim condensed consolidated financial statements for the periods ending September 30, 2025, and June 30, 2025. The financial report indicates a decrease in total assets from $763.6 million to $734.9 million, and a reduction in total liabilities from $468.4 million to $446.5 million. This financial update provides stakeholders with insights into the company’s current financial health and operational adjustments over the recent quarter.

Bioceres Crop Solutions Reports Q1 2026 Financial Results Amid Strategic Transition

Bioceres Crop Solutions reported its fiscal first quarter 2026 financial results, with total revenues of $77.5 million, marking a 17% decline year-over-year. Despite the revenue drop due to strategic reductions in low-margin sales and seed model transition, the company achieved a gross margin expansion from 40% to 47%, reflecting a more profitable product mix. The net loss widened to $7.5 million, but operating profit and adjusted EBITDA saw significant improvements, driven by cost discipline and restructuring efforts. The company remains focused on enhancing capital structure and financial flexibility amidst challenging market conditions in Argentina.

Bioceres Crop Solutions Faces Legal Action Over Alleged Defaults

On November 10, 2025, Bioceres Crop Solutions received an Acceleration Notice from its noteholders, alleging defaults under its Convertible and Non-Convertible Note Purchase Agreements. Subsequently, on November 11, 2025, these noteholders initiated legal proceedings against Bioceres in the New York Supreme Court, seeking full payment of outstanding amounts. Bioceres disputes the allegations and intends to defend its position vigorously, reserving all rights against the noteholders.

Bioceres Crop Solutions Strengthens Leadership with New Appointments

On November 5, 2025, Bioceres Crop Solutions Corp. announced the appointment of Mr. Simon Vumbaca to its Board of Directors and Mr. Alejandro Villafane as the Principal Accounting Officer. Mr. Vumbaca brings expertise in high-stakes strategies and governance, while Mr. Villafane will oversee the company’s accounting functions. These appointments are expected to strengthen Bioceres’ strategic and financial leadership, potentially enhancing its market position and operational resilience.

Bioceres Crop Solutions Faces Board Resignation Amid Financial Dispute

On September 30, 2025, Noah Kolatch resigned from the board of directors of Bioceres Crop Solutions Corp. following a reservation of rights letter from Jasper Lake Ventures One LLC. The letter, dated September 25, 2025, alleged several defaults under a Note Purchase Agreement. In response, Bioceres disputed these claims, emphasizing the importance of dialogue with Jasper Lake to address any concerns. The company remains committed to improving its commercial and financial performance while maintaining its focus on delivering innovative agricultural solutions.

Bioceres Crop Solutions Faces Challenging FY25 Amid Argentine Market Pressures

Bioceres Crop Solutions Corp. announced its financial results for the fourth fiscal quarter and full year 2025, highlighting a challenging year due to macroeconomic pressures in Argentina. The company reported a 40% decline in quarterly revenues to $74.7 million and a 28% decrease in annual revenues to $335.3 million, primarily due to weaker demand in Argentina and a strategic shift in its seed business. Despite these challenges, Bioceres is adjusting its cost structure and investment strategies to mitigate impacts, aiming for a 10-12% reduction in operating expenses and a significant cut in CAPEX and R&D investments. The company remains optimistic about future conditions and is taking steps to strengthen governance and financial management.

Bioceres Announces Departure of Chief Commercial Officer

Bioceres Crop Solutions Corp. announced the departure of its Chief Commercial Officer, Milen Marinov, effective August 31, 2025. Mr. Marinov also resigned from the company’s board of directors, with the decision not stemming from any disagreements regarding company operations or policies. The company is in the process of identifying a successor, which may impact its commercial strategies and stakeholder relations.